Linking Insulin Signaling to Antimicrobial Peptide Production and the Kidney's Antibacterial Defenses

将胰岛素信号转导与抗菌肽的产生和肾脏的抗菌防御联系起来

基本信息

项目摘要

ABSTRACT Diabetes mellitus is a systemic disorder that increases infection susceptibility. The most common site of infection is the urinary tract. Urinary tract infection (UTI) is more common, more severe, and has worse outcomes in people with diabetes. To date, the mechanisms that predispose people with diabetes to UTI have not been elucidated. This project will evaluate how insulin regulates innate immune mechanisms in the kidney’s intercalated cells. Surmounting evidence from our research group and others suggests that intercalated cells (IC) play a critical role in antibacterial defenses against uropathogenic E. coli (UPEC). Our research shows that insulin resistance and Type 2 diabetes mellitus increases UTI risk. When the insulin receptor is selectively deleted in murine ICs, UPEC susceptibility significantly increases in vivo. Also, we have demonstrated that insulin induces antimicrobial peptide (AMP) expression in primary human renal epithelial cells via the phosphatidylinositide 3-kinase (PI3K/AKT) signaling pathway. Specifically, our data show that insulin induces Ribonuclease 7 (RNase 7) production, the most potent AMP in the human urinary tract, to shield the urothelium from UPEC. Together, these data provide strong support for our hypothesis that insulin signaling plays an essential role in innate IC defenses by regulating PI3K/AKT activity and downstream AMP production. Building on these previous studies, we propose a comprehensive analysis of insulin’s ability to regulate IC defense mechanisms. Aim 1 will evaluate how insulin resistance and Type 2 diabetes mellitus affects IC antibacterial defenses. Aim 2 will identify how IC insulin receptor deletion impacts AMP transcription and whether targeted PI3K/AKT activation induces AMP expression. Aim 3 will use a novel transgenic humanized mouse model to assess how insulin resistance and insulin therapy impacts the production of RNase 7 and its antimicrobial activity in vivo. The long-term objective of this project is to improve the care of diabetic patients with UTI by identifying novel therapeutic options. By evaluating the role of insulin signaling in host defense, completion of these Aims can have profound influence on the health of people with diabetes as they may develop insulin-signaling targets, like PI3K/AKT and RNase 7, as new therapeutics that prevent UTI, extending UTI treatment options beyond the scope of antibiotics.
摘要

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

John David Spencer其他文献

Uropathogen and host responses in pyelonephritis
肾盂肾炎中的尿路致病菌和宿主反应
  • DOI:
    10.1038/s41581-023-00737-6
  • 发表时间:
    2023-07-21
  • 期刊:
  • 影响因子:
    39.800
  • 作者:
    Laura Schwartz;Juan de Dios Ruiz-Rosado;Emily Stonebrook;Brian Becknell;John David Spencer
  • 通讯作者:
    John David Spencer
Amplifying renal immunity: the role of antimicrobial peptides in pyelonephritis
增强肾脏免疫力:抗菌肽在肾盂肾炎中的作用
  • DOI:
    10.1038/nrneph.2015.105
  • 发表时间:
    2015-07-07
  • 期刊:
  • 影响因子:
    39.800
  • 作者:
    Brian Becknell;Andrew Schwaderer;David S. Hains;John David Spencer
  • 通讯作者:
    John David Spencer
Current and emerging strategies to curb antibiotic-resistant urinary tract infections
当前和新兴的遏制抗生素耐药性尿路感染的策略
  • DOI:
    10.1038/s41585-024-00877-9
  • 发表时间:
    2024-05-07
  • 期刊:
  • 影响因子:
    14.600
  • 作者:
    Aaron Simoni;Laura Schwartz;Guillermo Yepes Junquera;Christina B. Ching;John David Spencer
  • 通讯作者:
    John David Spencer
Prevalence and impact of abnormal blood pressure on left ventricular hypertrophy in adolescents with congenital heart disease
先天性心脏病青少年中异常血压的患病率及其对左心室肥厚的影响
  • DOI:
    10.1016/j.ajpc.2025.101001
  • 发表时间:
    2025-06-01
  • 期刊:
  • 影响因子:
    5.900
  • 作者:
    Aaron T Walsh;Kan N Hor;Mariah Eisner;Chance Alvarado;Mahmoud Kallash;John David Spencer;Andrew H Tran
  • 通讯作者:
    Andrew H Tran
Innate immunity and urinary tract infection
  • DOI:
    10.1007/s00467-019-04269-9
  • 发表时间:
    2019-06-13
  • 期刊:
  • 影响因子:
    2.600
  • 作者:
    Christina Ching;Laura Schwartz;John David Spencer;Brian Becknell
  • 通讯作者:
    Brian Becknell

John David Spencer的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('John David Spencer', 18)}}的其他基金

Insulin Signaling Activates Urothelial Defenses to Reduce Urinary Tract Infection Susceptibility
胰岛素信号激活尿路上皮防御,降低尿路感染易感性
  • 批准号:
    10364241
  • 财政年份:
    2021
  • 资助金额:
    $ 34.2万
  • 项目类别:
Insulin Signaling Activates Urothelial Defenses to Reduce Urinary Tract Infection Susceptibility
胰岛素信号激活尿路上皮防御,降低尿路感染易感性
  • 批准号:
    10673963
  • 财政年份:
    2021
  • 资助金额:
    $ 34.2万
  • 项目类别:
Linking Insulin Signaling to Antimicrobial Peptide Production and the Kidney's Antibacterial Defenses
将胰岛素信号转导与抗菌肽的产生和肾脏的抗菌防御联系起来
  • 批准号:
    10113589
  • 财政年份:
    2018
  • 资助金额:
    $ 34.2万
  • 项目类别:
The Contribution of Ribonuclease 7 to Urinary Tract Anitbacterial Defense
核糖核酸酶 7 对尿路抗菌防御的贡献
  • 批准号:
    9897601
  • 财政年份:
    2018
  • 资助金额:
    $ 34.2万
  • 项目类别:
Linking Insulin Signaling to Antimicrobial Peptide Production and the Kidney's Antibacterial Defenses
将胰岛素信号转导与抗菌肽的产生和肾脏的抗菌防御联系起来
  • 批准号:
    9523793
  • 财政年份:
    2018
  • 资助金额:
    $ 34.2万
  • 项目类别:
The Contribution of Ribonuclease 7 to Urinary Tract Anitbacterial Defense
核糖核酸酶 7 对尿路抗菌防御的贡献
  • 批准号:
    10348147
  • 财政年份:
    2018
  • 资助金额:
    $ 34.2万
  • 项目类别:
Novel Mouse Models to Assess the in vivo Significance of Ribonuclease 7 in Urinary Tract Defense
评估核糖核酸酶 7 在尿路防御中体内意义的新型小鼠模型
  • 批准号:
    9091881
  • 财政年份:
    2016
  • 资助金额:
    $ 34.2万
  • 项目类别:
Ribonuclease 7: Antimicrobial Activity in the Human Kidney and Urinary Tract
核糖核酸酶 7:人类肾脏和尿路的抗菌活性
  • 批准号:
    8461667
  • 财政年份:
    2012
  • 资助金额:
    $ 34.2万
  • 项目类别:
Ribonuclease 7: Antimicrobial Activity in the Human Kidney and Urinary Tract
核糖核酸酶 7:人类肾脏和尿路的抗菌活性
  • 批准号:
    8662257
  • 财政年份:
    2012
  • 资助金额:
    $ 34.2万
  • 项目类别:
Ribonuclease 7: Antimicrobial Activity in the Human Kidney and Urinary Tract
核糖核酸酶 7:人类肾脏和尿路的抗菌活性
  • 批准号:
    8917937
  • 财政年份:
    2012
  • 资助金额:
    $ 34.2万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了